OBJECTIVE: Carotid artery stenting (CAS) vs endarterectomy (CEA) remains controversial and has been the topic of recent randomized controlled trials. The purpose of this study was to compare the practice and outcomes of CAS and CEA in a real world setting. METHODS: This is a retrospective analysis of 7649 CEA and 430 CAS performed at 17 centers from 2003 to 2010 within the Vascular Study Group of New England (VSGNE). The primary outcome measures were (1) any in-hospital stroke or death and (2) any stroke, death, or myocardial infarction (MI). Patients undergoing CEA in conjunction with cardiac surgery were excluded. Multivariate logistic regression was performed to identify predictors of stroke or death in patients undergoing CAS. RESULTS: CEA was performed in 17 centers by 111 surgeons, while CAS was performed in 6 centers by 30 surgeons and 8 interventionalists. Patient characteristics varied by procedure. Patients undergoing CAS had a higher prevalence of coronary artery disease, congestive heart failure, diabetes, and prior ipsilateral CEA. Embolic protection was used in 97% of CAS. Shunts were used in 48% and patches in 86% of CEA. The overall in-hospital stroke or death rate was higher among patients undergoing CAS (2.3% vs 1.1%; P = .03). Overall stroke, death, or MI (2.8% CAS vs 2.1% CEA; P = .32) were not different. Asymptomatic patients had similar rates of stroke or death (CAS 0.73% vs CEA 0.89%; P = .78) and stroke, death, or MI (CAS 1.1% vs CEA 1.8%; P = .40). Symptomatic patients undergoing CAS had higher rates of stroke or death (5.1% vs 1.6%; P = .001), and stroke, death, or MI (5.8% vs 2.7%; P = .02). By multivariate analysis, major stroke (odds ratio, 4.5; 95% confidence interval [CI], 1.9-10.8), minor stroke (2.7; CI, 1.5-4.8), prior ipsilateral CEA (3.2, CI, 1.7-6.1), age >80 (2.1; CI, 1.3-3.4), hypertension (2.6; CI, 1.0-6.3), and a history of chronic obstructive pulmonary disease (1.6; CI, 1.0-2.4) were predictors of stroke or death in patients undergoing carotid revascularization. CONCLUSIONS: In our regional vascular surgical practices, the overall outcomes of CAS and CEA are similar for asymptomatic patients. However, symptomatic patients treated with CAS are at a higher risk for stroke or death.
OBJECTIVE: Carotid artery stenting (CAS) vs endarterectomy (CEA) remains controversial and has been the topic of recent randomized controlled trials. The purpose of this study was to compare the practice and outcomes of CAS and CEA in a real world setting. METHODS: This is a retrospective analysis of 7649 CEA and 430 CAS performed at 17 centers from 2003 to 2010 within the Vascular Study Group of New England (VSGNE). The primary outcome measures were (1) any in-hospital stroke or death and (2) any stroke, death, or myocardial infarction (MI). Patients undergoing CEA in conjunction with cardiac surgery were excluded. Multivariate logistic regression was performed to identify predictors of stroke or death in patients undergoing CAS. RESULTS:CEA was performed in 17 centers by 111 surgeons, while CAS was performed in 6 centers by 30 surgeons and 8 interventionalists. Patient characteristics varied by procedure. Patients undergoing CAS had a higher prevalence of coronary artery disease, congestive heart failure, diabetes, and prior ipsilateral CEA. Embolic protection was used in 97% of CAS. Shunts were used in 48% and patches in 86% of CEA. The overall in-hospital stroke or death rate was higher among patients undergoing CAS (2.3% vs 1.1%; P = .03). Overall stroke, death, or MI (2.8% CAS vs 2.1% CEA; P = .32) were not different. Asymptomatic patients had similar rates of stroke or death (CAS 0.73% vs CEA 0.89%; P = .78) and stroke, death, or MI (CAS 1.1% vs CEA 1.8%; P = .40). Symptomatic patients undergoing CAS had higher rates of stroke or death (5.1% vs 1.6%; P = .001), and stroke, death, or MI (5.8% vs 2.7%; P = .02). By multivariate analysis, major stroke (odds ratio, 4.5; 95% confidence interval [CI], 1.9-10.8), minor stroke (2.7; CI, 1.5-4.8), prior ipsilateral CEA (3.2, CI, 1.7-6.1), age >80 (2.1; CI, 1.3-3.4), hypertension (2.6; CI, 1.0-6.3), and a history of chronic obstructive pulmonary disease (1.6; CI, 1.0-2.4) were predictors of stroke or death in patients undergoing carotid revascularization. CONCLUSIONS: In our regional vascular surgical practices, the overall outcomes of CAS and CEA are similar for asymptomatic patients. However, symptomatic patients treated with CAS are at a higher risk for stroke or death.
Authors: Brahmajee K Nallamothu; Hitinder S Gurm; Henry H Ting; Philip P Goodney; Mary A M Rogers; Jeptha P Curtis; Justin B Dimick; Eric R Bates; Harlan M Krumholz; John D Birkmeyer Journal: JAMA Date: 2011-09-28 Impact factor: 56.272
Authors: S K Kakkos; A Nicolaides; M Griffin; M Sabetai; S Dhanjil; D J Thomas; T Sonecha; A M Salmasi; G Geroulakos; N Georgiou; S Francis; E Ioannidou; C J Dore Journal: Int Angiol Date: 2005-09 Impact factor: 2.789
Authors: A N Nicolaides; S K Kakkos; M Griffin; M Sabetai; S Dhanjil; T Tegos; D J Thomas; A Giannoukas; G Geroulakos; N Georgiou; S Francis; E Ioannidou; C J Doré Journal: Eur J Vasc Endovasc Surg Date: 2005-09 Impact factor: 7.069
Authors: P A Ringleb; J Allenberg; H Brückmann; H-H Eckstein; G Fraedrich; M Hartmann; M Hennerici; O Jansen; G Klein; A Kunze; P Marx; K Niederkorn; W Schmiedt; L Solymosi; R Stingele; H Zeumer; W Hacke Journal: Lancet Date: 2006-10-07 Impact factor: 79.321
Authors: R L Sacco; E J Benjamin; J P Broderick; M Dyken; J D Easton; W M Feinberg; L B Goldstein; P B Gorelick; G Howard; S J Kittner; T A Manolio; J P Whisnant; P A Wolf Journal: Stroke Date: 1997-07 Impact factor: 7.914
Authors: Lauren J Kim; Elizabeth A Martinez; Nauder Faraday; Todd Dorman; Lee A Fleisher; Bruce A Perler; G Melville Williams; Daniel Chan; Peter J Pronovost Journal: Circulation Date: 2002-10-29 Impact factor: 29.690
Authors: Margriet Fokkema; Rob Hurks; Thomas Curran; Rodney P Bensley; Allen D Hamdan; Mark C Wyers; Frans L Moll; Marc L Schermerhorn Journal: J Vasc Surg Date: 2013-08-28 Impact factor: 4.268
Authors: Albeir Y Mousa; Ali F AbuRahma; Joseph Bozzay; Mike Broce; Maher Kali; Michael Yacoub; Patrick Stone; Mark C Bates Journal: J Endovasc Ther Date: 2015-04-15 Impact factor: 3.487
Authors: Jesse A Columbo; Bjoern D Suckow; Claire L Griffin; Jack L Cronenwett; Philip P Goodney; Timothy G Lukovits; Robert M Zwolak; Mark F Fillinger Journal: J Vasc Surg Date: 2017-02-09 Impact factor: 4.268
Authors: Marc L Schermerhorn; Patric Liang; Jens Eldrup-Jorgensen; Jack L Cronenwett; Brian W Nolan; Vikram S Kashyap; Grace J Wang; Raghu L Motaganahalli; Mahmoud B Malas Journal: JAMA Date: 2019-12-17 Impact factor: 56.272
Authors: M Fokkema; G J de Borst; B W Nolan; J Indes; D B Buck; R C Lo; F L Moll; M L Schermerhorn Journal: Eur J Vasc Endovasc Surg Date: 2013-10-01 Impact factor: 7.069
Authors: Alexander B Pothof; Peter A Soden; Margriet Fokkema; Sara L Zettervall; Sarah E Deery; Thomas C F Bodewes; Gert J de Borst; Marc L Schermerhorn Journal: J Vasc Surg Date: 2017-06-24 Impact factor: 4.268
Authors: Jesse A Columbo; Pablo Martinez-Camblor; Todd A MacKenzie; Ravinder Kang; Spencer W Trooboff; Philip P Goodney; A James O'Malley Journal: J Vasc Surg Date: 2018-06-15 Impact factor: 4.268
Authors: Margriet Fokkema; Rodney P Bensley; Ruby C Lo; Allan D Hamden; Mark C Wyers; Frans L Moll; Gert Jan de Borst; Marc L Schermerhorn Journal: J Vasc Surg Date: 2013-02-04 Impact factor: 4.268
Authors: Marc L Schermerhorn; Margriet Fokkema; Philip Goodney; Ellen D Dillavou; Jeffrey Jim; Christopher T Kenwood; Flora S Siami; Rodney A White Journal: J Vasc Surg Date: 2013-02-11 Impact factor: 4.268
Authors: Jessica P Simons; Philip P Goodney; Donald T Baril; Brian W Nolan; Nathanael D Hevelone; Jack L Cronenwett; Louis M Messina; Andres Schanzer Journal: J Vasc Surg Date: 2013-02-08 Impact factor: 4.268